Ayesha Sattar, MD - Medicare Psychiatry in Oklahoma City, OK

Ayesha Sattar, MD is a medicare enrolled "Psychiatry & Neurology - Child & Adolescent Psychiatry" physician in Oklahoma City, Oklahoma. She graduated from medical school in 2004 and has 20 years of diverse experience with area of expertise as Psychiatry. She is a member of the group practice Uhs Oklahoma City Llc and her current practice location is 920 Stanton L Young Blvd # Wp3039, Oklahoma City, Oklahoma. You can reach out to her office (for appointments etc.) via phone at (405) 271-4219.

Ayesha Sattar is licensed to practice in Oklahoma (license number 30689) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1104232768.

Contact Information

Ayesha Sattar, MD
920 Stanton L Young Blvd # Wp3039,
Oklahoma City, OK 73104-5036
(405) 271-4219
Not Available



Physician's Profile

Full NameAyesha Sattar
GenderFemale
SpecialityPsychiatry
Experience20 Years
Location920 Stanton L Young Blvd # Wp3039, Oklahoma City, Oklahoma
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Ayesha Sattar graduated from medical school in 2004
  NPI Data:
  • NPI Number: 1104232768
  • Provider Enumeration Date: 07/03/2014
  • Last Update Date: 07/21/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 1557626181
  • Enrollment ID: I20180531000537

Medical Identifiers

Medical identifiers for Ayesha Sattar such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1104232768NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry 30689 (Oklahoma)Secondary
390200000XStudent In An Organized Health Care Education/training Program 30689 (Oklahoma)Secondary
2084P0804XPsychiatry & Neurology - Child & Adolescent Psychiatry 30689 (Oklahoma)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Uhs Oklahoma City Llc65078781133

News Archive

Temsirolimus effective for mRCC patients on hemodialysis

Research findings published in the International Journal of Clinical Oncology suggest that temsirolimus effectively stabilizes disease progression in patients with metastatic renal cell carcinoma undergoing hemodialysis.

Germ-killing robots use UV radiation to safeguard patients from health care-associated infections

Germ-killing robots are being enlisted to further safeguard Vanderbilt University Medical Center patients from health care-associated infections.

Repetitive subconcussive impacts trigger more changes in brain vital signs, research shows

Neuroscience researchers at Mayo Clinic Orthopedics and Sports Medicine in Rochester, Minnesota, U.S., the Health and Technology District and Simon Fraser University in Surrey, British Columbia, Canada have published the latest results of their ongoing multi-year hockey concussion study examining changes in subconcussive cognitive brain function in male youth ice hockey players.

Researchers find fear can increase or decrease ability to discriminate among sounds depending on context

Anyone who's ever heard a Beethoven sonata or a Beatles song knows how powerfully sound can affect our emotions. But it can work the other way as well - our emotions can actually affect how we hear and process sound.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for pancreatic cancer treatment

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Ayesha Sattar allows following entities to bill medicare on her behalf.
Entity NameNorman Regional Providers Specialty Care
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548513773
PECOS PAC ID: 5496900706
Enrollment ID: O20130312000200

News Archive

Temsirolimus effective for mRCC patients on hemodialysis

Research findings published in the International Journal of Clinical Oncology suggest that temsirolimus effectively stabilizes disease progression in patients with metastatic renal cell carcinoma undergoing hemodialysis.

Germ-killing robots use UV radiation to safeguard patients from health care-associated infections

Germ-killing robots are being enlisted to further safeguard Vanderbilt University Medical Center patients from health care-associated infections.

Repetitive subconcussive impacts trigger more changes in brain vital signs, research shows

Neuroscience researchers at Mayo Clinic Orthopedics and Sports Medicine in Rochester, Minnesota, U.S., the Health and Technology District and Simon Fraser University in Surrey, British Columbia, Canada have published the latest results of their ongoing multi-year hockey concussion study examining changes in subconcussive cognitive brain function in male youth ice hockey players.

Researchers find fear can increase or decrease ability to discriminate among sounds depending on context

Anyone who's ever heard a Beethoven sonata or a Beatles song knows how powerfully sound can affect our emotions. But it can work the other way as well - our emotions can actually affect how we hear and process sound.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for pancreatic cancer treatment

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.

Read more Medical News

› Verified 1 days ago

Entity NameUhs Oklahoma City Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1083985600
PECOS PAC ID: 6507878113
Enrollment ID: O20150427002122

News Archive

Temsirolimus effective for mRCC patients on hemodialysis

Research findings published in the International Journal of Clinical Oncology suggest that temsirolimus effectively stabilizes disease progression in patients with metastatic renal cell carcinoma undergoing hemodialysis.

Germ-killing robots use UV radiation to safeguard patients from health care-associated infections

Germ-killing robots are being enlisted to further safeguard Vanderbilt University Medical Center patients from health care-associated infections.

Repetitive subconcussive impacts trigger more changes in brain vital signs, research shows

Neuroscience researchers at Mayo Clinic Orthopedics and Sports Medicine in Rochester, Minnesota, U.S., the Health and Technology District and Simon Fraser University in Surrey, British Columbia, Canada have published the latest results of their ongoing multi-year hockey concussion study examining changes in subconcussive cognitive brain function in male youth ice hockey players.

Researchers find fear can increase or decrease ability to discriminate among sounds depending on context

Anyone who's ever heard a Beethoven sonata or a Beatles song knows how powerfully sound can affect our emotions. But it can work the other way as well - our emotions can actually affect how we hear and process sound.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for pancreatic cancer treatment

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.

Read more Medical News

› Verified 1 days ago

Entity NameAyesha Sattar Md Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1629737028
PECOS PAC ID: 8921491762
Enrollment ID: O20220131001578

News Archive

Temsirolimus effective for mRCC patients on hemodialysis

Research findings published in the International Journal of Clinical Oncology suggest that temsirolimus effectively stabilizes disease progression in patients with metastatic renal cell carcinoma undergoing hemodialysis.

Germ-killing robots use UV radiation to safeguard patients from health care-associated infections

Germ-killing robots are being enlisted to further safeguard Vanderbilt University Medical Center patients from health care-associated infections.

Repetitive subconcussive impacts trigger more changes in brain vital signs, research shows

Neuroscience researchers at Mayo Clinic Orthopedics and Sports Medicine in Rochester, Minnesota, U.S., the Health and Technology District and Simon Fraser University in Surrey, British Columbia, Canada have published the latest results of their ongoing multi-year hockey concussion study examining changes in subconcussive cognitive brain function in male youth ice hockey players.

Researchers find fear can increase or decrease ability to discriminate among sounds depending on context

Anyone who's ever heard a Beethoven sonata or a Beatles song knows how powerfully sound can affect our emotions. But it can work the other way as well - our emotions can actually affect how we hear and process sound.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for pancreatic cancer treatment

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ayesha Sattar is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Ayesha Sattar, MD
920 Stanton L Young Blvd # Wp3039,
Oklahoma City, OK 73104-5036

Ph: (405) 271-4219
Ayesha Sattar, MD
920 Stanton L Young Blvd # Wp3039,
Oklahoma City, OK 73104-5036

Ph: (405) 271-4219

News Archive

Temsirolimus effective for mRCC patients on hemodialysis

Research findings published in the International Journal of Clinical Oncology suggest that temsirolimus effectively stabilizes disease progression in patients with metastatic renal cell carcinoma undergoing hemodialysis.

Germ-killing robots use UV radiation to safeguard patients from health care-associated infections

Germ-killing robots are being enlisted to further safeguard Vanderbilt University Medical Center patients from health care-associated infections.

Repetitive subconcussive impacts trigger more changes in brain vital signs, research shows

Neuroscience researchers at Mayo Clinic Orthopedics and Sports Medicine in Rochester, Minnesota, U.S., the Health and Technology District and Simon Fraser University in Surrey, British Columbia, Canada have published the latest results of their ongoing multi-year hockey concussion study examining changes in subconcussive cognitive brain function in male youth ice hockey players.

Researchers find fear can increase or decrease ability to discriminate among sounds depending on context

Anyone who's ever heard a Beethoven sonata or a Beatles song knows how powerfully sound can affect our emotions. But it can work the other way as well - our emotions can actually affect how we hear and process sound.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for pancreatic cancer treatment

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.

Read more News

› Verified 1 days ago


Psychiatry & Neurology Doctors in Oklahoma City, OK

Lindsay Horn,
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 1140 N Hudson Ave, Oklahoma City, OK 73103
Phone: 405-858-2800    
Adil Tumbi, MD
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104
Phone: 405-271-5251    
Matthew Michael Ryan, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 800 N W 9th Street, Suite 100, Oklahoma City, OK 73106
Phone: 405-815-5050    Fax: 405-815-5051
Dr. Meheroz H Rabadi, M.D.
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104
Phone: 405-456-1000    Fax: 405-456-1504
Willis Holloway Jr., M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 6613 N Meridian Ave, Oklahoma City, OK 73116
Phone: 405-603-8450    Fax: 405-603-8455
Chauncey Atterberry, M.D.
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104
Phone: 405-456-1000    
Ethan D Lindsey, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 1117 Nw 50th St, Oklahoma City, OK 73118
Phone: 405-842-4435    Fax: 405-842-2846

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.